Neogenomics NEO
NASDAQ NEO
$16.42 -0.23 (-1.38%)
At close: Oct 19, 2026 · 4:00 PM EDT

Neogenomics (NEO) Notes Payables (2024 - 2025)

Updated

Neogenomics (NEO) recorded Notes Payables of $201.13 million in Q1 2025, up 0.2% from the prior quarter.

Analysis

Neogenomics (NEO) Notes Payables (2024 - 2025) Analysis & Trends

At the end of FY2024, Neogenomics reported Notes Payables of $200.78 million.

  • Per Business Quant, the preceding three quarters came in at $200.78 million (Q4 2024), $200.42 million (Q3 2024) and $200.07 million (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 100.51 Bn 96.52 Bn -
2 Natera 57.27 Bn 52.95 Bn 485.19 Mn
3 Quest Diagnostics 26.09 Bn 24.22 Bn 1.03 Bn
4 Labcorp Holdings 26.08 Bn 23.83 Bn 1.11 Bn
5 Tenet Healthcare 22.29 Bn 11.30 Bn -
6 Guardant Health 21.03 Bn 17.09 Bn 219.03 Mn
7 Fresenius Medical Care AG 12.78 Bn 4.73 Bn 1.52 Bn
8 BrightSpring Health Services 12.65 Bn 10.98 Bn 492.75 Mn
9 Davita 12.13 Bn 9.34 Bn 1.16 Bn
10 Neogenomics 2.13 Bn 1.51 Bn 91.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 201.13 Mn
Dec 31, 2024 200.78 Mn
Sep 30, 2024 200.42 Mn
Jun 30, 2024 200.07 Mn
API Access

Neogenomics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=NEO&period=max&api_key=YOUR_API_KEY